GAMMA Investing’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.29M Buy
31,810
+6,647
+26% +$593K 0.12% 133
2026
Q1
$1.81M Buy
25,163
+2,243
+10% +$173K 0.08% 210
2025
Q4
$1.82M Buy
22,920
+3,911
+21% +$308K 0.09% 181
2025
Q3
$1.43M Buy
19,009
+189
+1% +$13K 0.08% 210
2025
Q2
$1.3M Buy
18,820
+151
+0.8% +$9.9K 0.08% 214
2025
Q1
$1.26M Buy
18,669
+12,415
+199% +$743K 0.09% 192
2024
Q4
$281K Sell
6,254
-4,093
-40% -$230K 0.02% 561
2024
Q3
$651K Buy
10,347
+1,315
+15% +$76.7K 0.06% 270
2024
Q2
$533K Buy
9,032
+628
+7% +$39.3K 0.07% 249
2024
Q1
$670K Buy
8,404
+1,568
+23% +$120K 0.14% 137
2023
Q4
$508K Buy
+6,836
New +$487K 0.14% 124

Other funds holding CVS

GAMMA Investing's CVS Position: Q2 2026 in Review

GAMMA Investing increased its CVS Health (CVS) stake by 26% in Q2 2026, buying an estimated $593K and bringing the position to 31,810 shares worth $3.29M. The position accounts for 0.12% of the portfolio, ranked #133.

GAMMA Investing first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. 620 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • GAMMA Investing held 31,810 shares of CVS Health worth $3.29M as of Q2 2026.
  • GAMMA Investing bought 6,647 CVS Health shares in Q2 2026, an estimated $593K.
  • CVS Health made up 0.12% of GAMMA Investing's portfolio in Q2 2026, its #133 holding.
  • GAMMA Investing first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • 620 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.